Total Funding
27
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 27 in past quarter
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Fluence Therapeutics is a Biotechnology Therapeutics commercializing photodynamic therapy (PDT) for the treatment of psoriasis.
- Warren Cook: Chief Executive OfficerPast Role: CardioInsight Technologies, CEO
- Kevin D. Coope: Co-founder
About the Company
Fluence Therapeutics Inc. is a spinoff of Case Western Reserve University and University Hospitals Case Medical Center in Cleveland, Ohio USA commercializing photodynamic therapy (PDT) for the treatment of psoriasis and other skin diseases.
